Pitavastatin
- Generic Name
- Pitavastatin
- Brand Names
- Livalo, Zypitamag
- Drug Type
- Small Molecule
- Chemical Formula
- C25H24FNO4
- CAS Number
- 147511-69-1
- Unique Ingredient Identifier
- M5681Q5F9P
- Background
Pitavastatin, also known as the brand name product Livalo, is a lipid-lowering drug belonging to the statin class of medications. By inhibiting the endogenous production of cholesterol within the liver, statins lower abnormal cholesterol and lipid levels and ultimately reduce the risk of cardiovascular disease. More specifically, statin medications competiti...
- Indication
用于治疗高胆固醇症(高脂血症)、家族性高胆固醇症。
- Associated Conditions
- Apolipoprotein B increased, Elevation of serum triglyceride levels, Increases in serum total low-density lipoprotein (LDL), Increases in total cholesterol
- Associated Therapies
- -
Yokohama Assessment of Fluvastatin, Pravastatin, Pitavastatin and Atorvastatin in Acute Coronary Syndrome (Yokohama-ACS)
- Conditions
- Interventions
- First Posted Date
- 2007-10-26
- Last Posted Date
- 2010-02-17
- Lead Sponsor
- Yokohama City University Medical Center
- Target Recruit Count
- 200
- Registration Number
- NCT00549926
- Locations
- 🇯🇵
Yokohama City University Medical Center, Yokohama, Japan
The Clinical Study of Pitavastatin Treatment for Group of Mild to Moderate Alzheimer's Disease
- Conditions
- Interventions
- First Posted Date
- 2007-10-23
- Last Posted Date
- 2012-06-14
- Lead Sponsor
- Osaka University
- Target Recruit Count
- 38
- Registration Number
- NCT00548145
- Locations
- 🇯🇵
Osaka University Hospital, Suita, Osaka, Japan
Impact of Pitavastatin in Hypercholesterolemic Patients With Metabolic Syndrome
- Conditions
- First Posted Date
- 2007-03-08
- Last Posted Date
- 2011-07-13
- Lead Sponsor
- Aichi Gakuin University
- Target Recruit Count
- 100
- Registration Number
- NCT00444717
- Locations
- 🇯🇵
Tatsuaki Matsubara, Nagoya, Aichi, Japan
Follow-on Protocol of Pitavastatin Versus Simvastatin in Patients With Hypercholesterolemia or Dyslipidemia and Coronary Heart Disease Risk Factors
- Conditions
- Interventions
- First Posted Date
- 2006-06-26
- Last Posted Date
- 2010-02-02
- Lead Sponsor
- Kowa Research Europe
- Target Recruit Count
- 178
- Registration Number
- NCT00344175
- Locations
- 🇸🇪
Huslakaren i Sandviken, Sandviken, Sweden
🇸🇪Hjarthuset AB, Varberg, Sweden
🇳🇱Kamerlingh Onnesstraat 16-18, Nijmegen, Netherlands
Follow-On Study of Pitavastatin Versus Atorvastatin in Patients With Type II Diabetes Mellitus and Combined Dyslipidemia
- Conditions
- Interventions
- First Posted Date
- 2006-06-26
- Last Posted Date
- 2010-02-02
- Lead Sponsor
- Kowa Research Europe
- Target Recruit Count
- 214
- Registration Number
- NCT00344370
- Locations
- 🇮🇳
Sri Ramachandra Medical College Hospital, Chennai, India
🇮🇳Apollo Hospitals, Hyderabaad, India
🇵🇱Szpital Wolski,im. Dr A. Gostynskiej, Warszawa, Poland
Study of Pitavastatin in Elderly Patients With Primary Hypercholesterolemia or Combined Dyslipidemia
- First Posted Date
- 2006-05-29
- Last Posted Date
- 2010-03-16
- Lead Sponsor
- Kowa Research Europe
- Target Recruit Count
- 545
- Registration Number
- NCT00330876
- Locations
- 🇮🇱
Center for Research, Hadassah University Hospital, Jerusalem Ein Kerem, Israel
🇮🇱Meir Hospital, Kfar Saba, Israel
🇮🇱Department of Medicine, Hadassah Medical Center, Mount Scopus Jerusalem, Israel
Long-Term Extension Study of Pitavastatin in Patients With Primary Hypercholesterolemia or Combined Dyslipidemia
- First Posted Date
- 2006-05-15
- Last Posted Date
- 2010-02-02
- Lead Sponsor
- Kowa Research Europe
- Target Recruit Count
- 1355
- Registration Number
- NCT00325780
- Locations
- 🇩🇰
Medical Center, Copenhagen, Denmark
🇷🇺City Clinical Hospital 64, Moscow, Russian Federation
🇪🇸Hospital Universitario Reina Sofia, Cordoba, Spain
Study Comparing Pitavastatin and Atorvastatin in Patients With Type II Diabetes Mellitus and Combined Dyslipidemia
- Conditions
- Interventions
- First Posted Date
- 2006-04-03
- Last Posted Date
- 2010-02-23
- Lead Sponsor
- Kowa Research Europe
- Target Recruit Count
- 418
- Registration Number
- NCT00309751
- Locations
- 🇳🇱
Andromed Eindhoven, Eindhoven, Netherlands
🇳🇱Andromed Nijmegen, Nijmegen, Netherlands
🇩🇰CCBR Aalborg, Aalborg, Denmark
Study to Compare the Efficacy and Safety of Pitavastatin and Simvastatin
- Conditions
- Interventions
- First Posted Date
- 2006-04-03
- Last Posted Date
- 2010-03-16
- Lead Sponsor
- Kowa Research Europe
- Target Recruit Count
- 355
- Registration Number
- NCT00309738
- Locations
- 🇸🇪
Hjarthuset AB, Varberg, Sweden
🇪🇸Hospital Vall d'Hebron, Barcelona, Spain
🇸🇪Angelholms Sjukhus, Medicinkliniken, Angelhom, Sweden
Study to Compare the Efficacy and Safety of Pitavastatin and Simvastatin
- Conditions
- Interventions
- First Posted Date
- 2006-04-03
- Last Posted Date
- 2010-01-12
- Lead Sponsor
- Kowa Research Europe
- Target Recruit Count
- 857
- Registration Number
- NCT00309777
- Locations
- 🇳🇴
Radhuset Spesialistsenter, Oslo, Norway
🇷🇺Kemerovo Cardiology Dispensary, Kemerovo, Russian Federation
🇫🇮Keravan Laakarikeskus, Helsinki, Finland
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.